Evidence-Based Decision Making for Patients, Providers, and Policymakers in the Prevention of Sudden Cardiac Death
Gillian Sanders-Schmidler, PhD
Professor of Medicine
Duke Clinical Research Institute, Duke University
Back in the 1990s the Stanford Cardiac Patient Outcome Research Team (PORT) was funded by AHRQ to examine the effectiveness and cost-effectiveness of strategies to manage life-threatening arrhythmias in patients with heart disease. The clinical and policy questions which this collaboration sought to explore were informed by decision modeling, systematic reviews of the evidence, primary data collection, and an interdisciplinary team of researchers. Over the next twenty plus years, several RCTs have explored the effectiveness of alternative strategies in various patient populations, coverage decisions and policymakers have influenced the dissemination of therapies and the data collected, and researchers have continually sought to explore what is the natural history of sudden cardiac death, what is the comparative effectiveness of available treatments, and how can evidence-based findings be disseminated in to policy and practice (and reflect patient preferences)? In this talk I will summarize our past research in this clinical and policy area – and highlight areas of future needed research.
Dr. Gillian D. Sanders-Schmidler is a member of the Outcomes Research and Assessment Group within the DCRI and a Professor in the Division of Clinical Pharmacology, Department of Medicine at Duke University Medical Center. Dr. Sanders-Schmidler received her undergraduate degree in Mathematics from Princeton University in 1993 and her doctorate in Medical Informatics from Stanford University in 1998. Dr. Sanders-Schmidler was an Assistant Professor of Medicine at Stanford’s Center for Primary Care and Outcomes Research from 1998 until the fall of 2003 when she joined the faculty at Duke University.
Dr. Sanders-Schmidler's research focuses on the development of evidence-based decision models to evaluate the comparative effectiveness of alternative prevention, treatment, and management strategies for chronic diseases – and the translation of such models into formats/tools that patients, healthcare providers, and policymakers can use in their decision-making process. Dr. Sanders-Schmidler is Past President of the Society for Medical Decision Making (SMDM) and served as Director of Duke’s Evidence-based Practice Center (EPC III) funded by the Agency for Healthcare Research and Quality (AHRQ) from 2009-2013 and of EPC V 2014-2019. She directs Duke’s Evidence Synthesis Group. Dr. Sanders-Schmidler has extensive research expertise in both methodology and application of comparative effectiveness and patient-centered outcomes research and leading collaborative investigator teams to perform successful and high-quality systematic review of the literature. She is currently co-chairing the 2nd Panel for Cost Effectiveness in Health and Medicine.
Lunch provided to those who RSVP.